Psychiatric Annals

ABOUT THE GUEST EDITOR 

Norman S. Miller, MD

Abstract

Norman S. Miller, MD, is Professor of Psychiatry and Medicine in the College of Human Medicine, and Director of Addiction Medicine, Michigan State University. He is a medical consultant for the Department of Community Health in the state of Michigan. He is a deputy medical examiner in Ingham County, Michigan. His clinical and research interests include treatment outcome, benzodiazepines, and medical education.

Dr. Miller is a member of Alpha Omega Alpha, and a graduate of Howard University Medical College. He is certified in addiction medicine. He is a diplomate of the American Board of Psychiatry and Neurology, separately in psychiatry, neurology, and addiction psychiatry. Dr. Miller completed a residency in psychiatry at Johns Hopkins Hospital, and a residency in neurology and a fellowship in clinical pharmacology at the University of Minnesota. He appears in Who's Who in America (and International). Dr. Miller is president of the Illinois Society of Addiction Medicine. For the American Society of Addiction Medicine (ASAM), he is regional director of the midwest region, editor of Principles of Addiction Medicine (first edition), and serves on program and publication committees. He has coordinated and participated in symposia, courses, and workshops for the American Psychiatric Association's annual meeting.

Dr. Miller speaks before national and international audiences, and presents at state and federal conferences as well as universities and medical schools. He has published more than 250 medical /scientific articles, book chapters, and reviews, and 12 books on addiction medicine. He is a fellow in the American Psychopathological Association, and a member of the American Psychiatric Association, the American Society of Addiction Medicine, and the American National Professional Committee. He has served as a member of the Task Force on Treatment for the Office of National Drug Control Policy (ONDCP), Office of the President of the United States; a member of the Center for Substance Abuse Treatment (CSAT) on Screening, Assessment, and Treatment Planning for Patients with Coexisting Mental Illness and Alcohol and Other Drug (AOD) Abuse; and co-chair of the Task Force for Undergraduate Medical Education, Association for Medical Education and Research in Substance Abuse (AMERSA).…

Norman S. Miller, MD, is Professor of Psychiatry and Medicine in the College of Human Medicine, and Director of Addiction Medicine, Michigan State University. He is a medical consultant for the Department of Community Health in the state of Michigan. He is a deputy medical examiner in Ingham County, Michigan. His clinical and research interests include treatment outcome, benzodiazepines, and medical education.

Dr. Miller is a member of Alpha Omega Alpha, and a graduate of Howard University Medical College. He is certified in addiction medicine. He is a diplomate of the American Board of Psychiatry and Neurology, separately in psychiatry, neurology, and addiction psychiatry. Dr. Miller completed a residency in psychiatry at Johns Hopkins Hospital, and a residency in neurology and a fellowship in clinical pharmacology at the University of Minnesota. He appears in Who's Who in America (and International). Dr. Miller is president of the Illinois Society of Addiction Medicine. For the American Society of Addiction Medicine (ASAM), he is regional director of the midwest region, editor of Principles of Addiction Medicine (first edition), and serves on program and publication committees. He has coordinated and participated in symposia, courses, and workshops for the American Psychiatric Association's annual meeting.

Dr. Miller speaks before national and international audiences, and presents at state and federal conferences as well as universities and medical schools. He has published more than 250 medical /scientific articles, book chapters, and reviews, and 12 books on addiction medicine. He is a fellow in the American Psychopathological Association, and a member of the American Psychiatric Association, the American Society of Addiction Medicine, and the American National Professional Committee. He has served as a member of the Task Force on Treatment for the Office of National Drug Control Policy (ONDCP), Office of the President of the United States; a member of the Center for Substance Abuse Treatment (CSAT) on Screening, Assessment, and Treatment Planning for Patients with Coexisting Mental Illness and Alcohol and Other Drug (AOD) Abuse; and co-chair of the Task Force for Undergraduate Medical Education, Association for Medical Education and Research in Substance Abuse (AMERSA).

10.3928/0048-5713-20000901-04

Sign up to receive

Journal E-contents